Biotech Marvel: PepGen Welcomes Kasra Kasraian as New CTO
In a strategic move to enhance its technological prowess, PepGen Inc. (Nasdaq: PEPG), a trailblazer in biotechnology, has appointed Dr. Kasra Kasraian as its new Chief Technology Officer. This decision aligns with the company’s mission to revolutionize the treatment of severe neuromuscular and neurological disorders.
A Leader with Proven Expertise
Dr. Kasraian comes to PepGen with over 25 years of invaluable experience in product and process development, extending from small molecules to complex gene therapies. His journey includes pivotal roles at bluebird bio, where his leadership in regulatory and CMC sciences led to the successful approval of innovative gene therapies such as SKYSONA™, ZYNTEGLO™, and LYFGENIA™.
Vision for PepGen’s Future
“With Kasra’s inclusion, we are poised to transform treatment modalities offered to patients with grievous conditions,” stated James McArthur, PepGen’s CEO. Dr. Kasraian’s adeptness at navigating the intricate landscapes of manufacturing and regulatory processes is seen as pivotal for the company’s progress into mid-stage clinical development.
Enhancing About PepGen’s Mission
PepGen continues to lead with its EDO platform, a decade-long venture into the development of oligonucleotide therapies. These cell-penetrating peptides serve as a cornerstone in improving the uptake and functionality of therapeutic candidates. According to BioSpace, the company’s initiatives are designed to tackle the root causes of serious health challenges.
Building on a Solid Foundation
Dr. Kasraian’s academic background is as impressive as his career trajectory, with a PhD in Pharmaceutical Sciences and a BS in Chemical Engineering from the University of Kentucky. His scientific acumen has been instrumental in various roles at Biogen, Wyeth Biotech, Pfizer Inc., and Genetics Institute, contributing to both small molecule and biologics development.
This strategic appointment underscores PepGen’s commitment to fostering innovation and delivering life-changing therapies. The future looks promising with Dr. Kasraian steering the helm of technology development.
Stay updated on PepGen’s path forward by following their latest initiatives online.
